BioCentury | Jan 18, 2018
Translation in Brief

A notch for tankyrase

...on Wnt signaling. In July, 2X Oncology Inc. acquired the rights to Eisai’s 2X-121 (previously E7449...
BioCentury | Jul 14, 2017
Company News

Eisai grants 2XOncology rights to 2X-121

...Oncology Inc. (Cambridge, Mass.) exclusive, worldwide rights to develop and commercialize cancer candidate 2X-121 (previously E7449...
...ankyrin-related ADP-ribose polymerase ( TNKS ; TNKS1) and TNKS2 . 2X Oncology plans to develop 2X-121... Eisai. Eisai declined to disclose additional details. 2X Oncology did not respond to inquiries. Shannon Lehnbeuter 2X-121 2X...
Items per page:
1 - 2 of 2